Tongjitang Chinese Medicines Company to Announce Third Quarter 2008 Financial Results on November 25, 2008

SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (NYSE: TCM - News), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it plans to announce its third quarter 2008 financial results before the market opens on Tuesday, November 25, 2008.

Tongjitang’s management team will hold a conference call the same day at 8:00 a.m. U.S. Eastern Time (9:00 p.m. Beijing/Hong Kong time) following the announcement. Listeners may access the call by dialing the following numbers:

United States toll free: 1-888-455-2238

Hong Kong toll free: 800-968-103

Northern China toll free: 10 800 712 0046

Southern China toll free: 10 800 120 0046

International: 1-719-325-2377

Listeners may access the replay through December 2, 2008, by dialing the following numbers:

United States toll free: 1-888-203-1112

International: 1-719-457-0820

Password: 4128255

An audio webcast of the call will also be available through the Company’s website at www.tongjitang.com.

About Tongjitang Chinese Medicines Company

Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, and Tongjitang Planting, is a vertically integrated and profitable specialty pharmaceutical company focused on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China. Tongjitang’s principal executive offices are located in Shenzhen, China.

Tongjitang’s flagship product, Xianling Gubao, is the leading traditional Chinese medicine for the treatment of osteoporosis in China as measured by sales in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets 18 other modernized traditional Chinese medicine products and 38 western medicines. Please visit www.tongjitang.com for more information.